Lack of prognostic significance of adiponectin immunohistochemical expression in patients with triplenegative breast cancer

ÇUBUKÇU, ERDEM; Olmez, Omer; Kanat, Ozkan; Kabul, SELVA; Canhoroz, Mustafa; Avci, Nilufer; Hartavi, Mustafa; DELİGÖNÜL, ADEM; Cubukcu, Sinem; Manavoglu, Osman

doi:10.5114/wo.2014.40454

Lack of prognostic significance of adiponectin immunohistochemical expression in patients with triplenegative breast cancer

ÇUBUKÇU E., Olmez O. F., Kanat O., Kabul S., Canhoroz M., Avci N., ...Daha Fazla

WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, cilt.18, sa.1, ss.34-38, 2014 (ESCI, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 18 Sayı: 1
Basım Tarihi: 2014
Doi Numarası: 10.5114/wo.2014.40454
Dergi Adı: WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
Sayfa Sayıları: ss.34-38
Anahtar Kelimeler: triple-negative breast cancer, adiponectin, immunohistochemistry, prognosis
Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Introduction: Triple-negative breast cancers (TNBCs) -which lack the expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER-2)-have no established markers that can be used for prognostic stratification. As adiponectin has been previously implicated in a more aggressive phenotype of primary breast cancer, we explored the relation between adiponectin immunohistochemical expression and prognosis in TNBCs.